COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 155 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $349,000 | -50.7% | 20,008 | -43.4% | 0.00% | -50.0% |
| Q1 2022 | $708,000 | +247.1% | 35,328 | +239.7% | 0.00% | +100.0% |
| Q3 2021 | $204,000 | -19.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | +2.0% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $247,000 | +20.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $205,000 | +0.5% | 10,400 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $204,000 | -28.7% | 10,400 | -51.9% | 0.00% | 0.0% |
| Q2 2019 | $286,000 | +29.4% | 21,600 | +63.6% | 0.00% | 0.0% |
| Q1 2019 | $221,000 | +25.6% | 13,200 | +22.2% | 0.00% | 0.0% |
| Q4 2018 | $176,000 | -20.4% | 10,800 | -18.2% | 0.00% | 0.0% |
| Q3 2018 | $221,000 | -32.8% | 13,200 | -2.2% | 0.00% | -50.0% |
| Q2 2018 | $329,000 | -2.7% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $338,000 | +96.5% | 13,500 | +33.7% | 0.00% | 0.0% |
| Q1 2016 | $172,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |